Change in cardio-ankle vascular index by long-term continuous positive airway pressure therapy for obstructive sleep apnea

Journal of Cardiology

Volumn 58, Issue 1, 2011, Pages 74-82

  Kato, Mitsue ^a   Kumagai, Takiko ^a   Naito, Ryo ^a   Maeno, Ken ^a   Kasagi, Satoshi ^a   Kawana, Fusae ^a   Ishiwata, Sugao ^a   Narui, Koji ^a   Kasai, Takatoshi ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Aging; Atherosclerosis; Blood pressure; Ventilation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OXYHEMOGLOBIN; TRIACYLGLYCEROL;

ADULT; AGED; AROUSAL; ARTICLE; BODY MASS; CARDIOANKLE VASCULAR INDEX; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EPWORTH SLEEPINESS SCALE; FEMALE; FOLLOW UP; HEART RATE; HEART RATE VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; REM SLEEP; SLEEP APNEA SYNDROME; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ANKLE; ARTERIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE;

EID: 80955177066     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.03.005     Document Type: Article

References (43)

1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
2. Peker Y., Hedner J., Norum J., Kraiczi H., Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002, 166:159-165.
3. Punjabi N.M., Caffo B.S., Goodwin J.L., Gottlieb D.J., Newman A.B., O'Connor G.T., Rapoport D.M., Redline S., Resnick H.E., Robbins J.A., Shahar E., Unruh M.L., Samet J.M. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6:e1000132.
4. Redline S., Yenokyan G., Gottlieb D.J., Shahar E., O'Connor G.T., Resnick H.E., Diener-West M., Sanders M.H., Wolf P.A., Geraghty E.M., Ali T., Lebowitz M., Punjabi N.M. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010, 182:269-277.
5. Gottlieb D.J., Yenokyan G., Newman A.B., O'Connor G.T., Punjabi N.M., Quan S.F., Redline S., Resnick H.E., Tong E.K., Diener-West M., Shahar E. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010, 122:352-360.
6. Ishibashi Y., Osada N., Sekiduka H., Izumo M., Shimozato T., Hayashi A., Kida K., Yoneyama K., Takahashi E., Suzuki K., Tamura M., Akashi Y.J., Inoue K., Omiya K., Miyake F., et al. Peak time of acute coronary syndrome in patients with sleep disordered breathing. J Cardiol 2009, 53:164-170.
7. Koshino Y., Satoh M., Katayose Y., Kuroki K., Sekiguchi Y., Yamasaki H., Yoshida K., Yasuda K., Tanigawa T., Kuga K., Aonuma K. Sleep apnea and ventricular arrhythmias: clinical outcome, electrophysiologic characteristics, and follow-up after catheter ablation. J Cardiol 2010, 55:211-216.
8. Tamura A., Kawano Y., Ando S., Watanabe T., Kadota J. Association between coronary spastic angina pectoris and obstructive sleep apnea. J Cardiol 2010, 56:240-244.
9. Young T., Shahar E., Nieto F.J., Redline S., Newman A.B., Gottlieb D.J., Walsleben J.A., Finn L., Enright P., Samet J.M. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002, 162:893-900. Sleep Heart Health Study Research Group.
10. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
11. Punjabi N.M., Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005, 99:1998-2007.
12. Somers V.K., Dyken M.E., Clary M.P., Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96:1897-1904.
13. Ryan S., Taylor C.T., McNicholas W.T. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?. Thorax 2009, 64:631-636.
14. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 2003, 7:35-51.
15. Drager L.F., Bortolotto L.A., Lorenzi M.C., Figueiredo A.C., Krieger E.M., Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005, 172:613-618.
16. Jelic S., Bartels M.N., Mateika J.H., Ngai P., DeMeersman R.E., Basner R.C. Arterial stiffness increases during obstructive sleep apneas. Sleep 2002, 25:850-855.
17. Shiina K., Tomiyama H., Takata Y., Usui Y., Asano K., Hirayama Y., Nakamura T., Yamashina A. Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study. Hypertens Res 2006, 29:433-441.
18. Yim-Yeh S., Rahangdale S., Nguyen A.T., Jordan A.S., Novack V., Veves A., Malhotra A. Obstructive sleep apnea and aging effects on macrovascular and microcirculatory function. Sleep 2010, 33:1177-1183.
19. Kitahara Y., Hattori N., Yokoyama A., Nakajima M., Kohno N. Effect of CPAP on brachial-ankle pulse wave velocity in patients with OSAHS: an open-labelled study. Respir Med 2006, 100:2160-2169.
20. Drager L.F., Bortolotto L.A., Figueiredo A.C., Krieger E.M., Lorenzi G.F. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007, 176:706-712.
21. Kohler M., Pepperell J.C., Casadei B., Craig S., Crosthwaite N., Stradling J.R., Davies R.J. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 2008, 32:1488-1496.
22. Phillips C.L., Yee B., Yang Q., Villaneuva A.T., Hedner J., Berend N., Grunstein R. Effects of continuous positive airway pressure treatment and withdrawal in patients with obstructive sleep apnea on arterial stiffness and central BP. Chest 2008, 134:94-100.
23. Shiina K., Tomiyama H., Takata Y., Yoshida M., Kato K., Saruhara H., Hashimura Y., Matsumoto C., Asano K., Usui Y., Yamashina A. Effects of CPAP therapy on the sympathovagal balance and arterial stiffness in obstructive sleep apnea. Respir Med 2010, 104:911-916.
24. Kuramoto E., Kinami S., Ishida Y., Shiotani H., Nishimura Y. Continuous positive nasal airway pressure decreases levels of serum amyloid A and improves autonomic function in obstructive sleep apnea syndrome. Int J Cardiol 2009, 135:338-345.
25. Yambe T., Yoshizawa M., Saijo Y., Yamaguchi T., Shibata M., Konno S., Nitta S., Kuwayama T. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother 2004, 58(Suppl. 1):S95-S98.
26. Shirai K., Utino J., Otsuka K., Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 2006, 13:101-107.
27. Kumagai T., Kasai T., Kato M., Naito R., Maeno K., Kasagi S., Kawana F., Ishiwata S., Narui K. Establishment of the cardio-ankle vascular index in patients with obstructive sleep apnea. Chest 2009, 136:779-786.
28. Kasai T., Inoue K., Kumagai T., Kato M., Kawana F., Sagara M., Ishiwata S., Ohno M., Yamaguchi T., Momomura S., Narui K. Plasma pentraxin3 and arterial stiffness in men with obstructive sleep apnea. Am J Hypertens 2011, 24:401-407.
29. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999, 22:667-689.
30. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
31. Safar M.E., Levy B.I., Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003, 107:2864-2869.
32. Zieman S.J., Melenovsky V., Kass D.A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005, 25:932-943.
33. Ip M.S., Tse H.F., Lam B., Tsang K.W., Lam W.K. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004, 169:348-353.
34. Narkiewicz K., Kato M., Phillips B.G., Pesek C.A., Davison D.E., Somers V.K. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999, 100:2332-2335.
35. Saito T., Saito T., Sugiyama S., Asai K., Yasutake M., Mizuno K. Effects of long-term treatment for obstructive sleep apnea on pulse wave velocity. Hypertens Res 2010, 33:844-849.
36. Tomiyama H., Yamashina A., Arai T., Hirose K., Koji Y., Chikamori T., Hori S., Yamamoto Y., Doba N., Hinohara S. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement-a survey of 12517 subjects. Atherosclerosis 2003, 166:303-309.
37. Garcia-Rio F., Pino J.M., Alonso A., Arias M.A., Martinez I., Alvaro D., Villamor J. White coat hypertension in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2004, 125:817-822.
38. Lam J.C., Lam B., Yao T.J., Lai A.Y., Ooi C.G., Tam S., Lam K.S., Ip M.S. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J 2010, 35:138-145.
39. Miyashita Y., Saiki A., Endo K., Ban N., Yamaguchi T., Kawana H., Nagayama D., Ohira M., Oyama T., Shirai K. Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension. J Atheroscler Thromb 2009, 16:621-626.
40. Bokuda K., Ichihara A., Sakoda M., Mito A., Kinouchi K., Itoh H. Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome. Vasc Health Risk Manage 2010, 6:571-578.
41. Miyoshi T, Doi M, Hirohata S, Kamikawa S, Usui S, Ogawa H, Sakane K, Izumi R, Ninomiya Y, Kusachi S. Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients. Heart Vessels 2010 November 10 [Epub ahead of print].
42. Noike H., Nakamura K., Sugiyama Y., Iizuka T., Shimizu K., Takahashi M., Hirano K., Suzuki M., Mikamo H., Nakagami T., Shirai K. Changes in cardio-ankle vascular index in smoking cessation. J Atheroscler Thromb 2010, 17:517-525.
43. Kubozono T., Miyata M., Ueyama K., Hamasaki S., Kusano K., Kubozono O., Tei C. Acute and chronic effects of smoking on arterial stiffness. Circ J 2011, 75:698-702.